To mark World Cancer Research Day on 24 September 2018, the Snowdome Foundation is pleased to announce a new collaboration with Australian Cancer Research Foundation (ACRF). This will further enhance cancer research capacity in Australia and increase collaboration between cancer research funders.
ACRF provides outstanding Australian researchers with state-of-the-art equipment they need to improve prevention, diagnosis and treatment of all types of cancer. The new collaborations will provide additional funds to support researchers that operate equipment acquired with an ACRF grant. This ensures that the equipment will be used for maximum impact and efficiency.
ACRF Chief Executive Officer Professor Ian Brown says that the new collaborations are an excellent way to enhance the impact and improve the efficiency of funding for Australian cancer research.
“The benefit of the collaborations announced today mark a significant saving on resources and time for researchers. Less time will be spent on writing additional funding applications, allowing researchers to spend time on what really matters – cancer research.”
ACRF grant applications are assessed annually by the Medical Research Advisory Committee, comprising esteemed Australian and international cancer researchers and clinicians who volunteer their time. The Committee ensures that the most promising and impactful cancer research initiatives in Australia are recommended to the Board of Trustees to receive ACRF funding.
“These collaborations are a tremendous acknowledgement of the reputation and integrity of ACRF and its grant selection and governance procedures. We look forward to giving researchers not only the most advanced tools they need to outsmart cancer, but also simplifying the provision of human power to make it all happen.”
Snowdome CEO Miriam Dexter says “The Snowdome Foundation is pleased to be collaborating with ACRF to advance translational blood cancer research. ACRF brings a national approach as well as a transparent, peer-reviewed grant review process. Further, by leveraging each organisation’s key funding focus, we are able to match hi-tech equipment with vital human infrastructure resulting in fast-tracking next-generation blood cancer treatments and ‘making hope real’ for Australian blood cancer patients.”
The current agreement will be in place until 2020.
— ends —
For more information or to arrange an interview with CEO Ian Brown, please contact Michaela Lauren (02)-9223 7833 or email email@example.com.
About the Australian Cancer Research Foundation
At ACRF we believe that together we can outsmart all cancers, and we won’t stop until we do. Thanks to the generosity of our supporters, we fund technology to speed up research into prevention, diagnosis and treatment of ALL types of cancer, ALL across Australia. Since 1984, ACRF has proudly funded 69 ground-breaking cancer research projects at 37 research institutions across Australia. Find out more at acrf.com.au
About the Snowdome Foundation
Snowdome was formed in 2010 with a mission to accelerate next-generation treatments for Australian blood cancer (myeloma, lymphoma and leukaemia) patients to help them live longer, better lives. It aims to accelerate access to innovative blood cancer treatments by channelling government and private philanthropic investments into ground breaking research, clinical trials, and personalised therapies. To date, Snowdome has raised almost $25 million and Snowdome support has assisted 348 Australian blood cancer patients to gain access to 18 early-phase clinical trials. Find out more at www.snowdome.org.au